The historical rank and industry rank for Apex Healthcare Bhd's Gross Margin % or its related term are showing as below:
XKLS:7090'
s Gross Margin % Range Over the Past 10 Years
Min: 20.88 Med: 22.49 Max: 23.77
Current: 23.42
During the past 13 years, the highestGross Margin % of Apex Healthcare Bhd was 23.77%. The lowest was 20.88%. And the median was 22.49%.
XKLS:7090's Gross Margin % is not ranked
in the Medical Distribution industry.
Industry Median: 14.9
vs XKLS:7090: 23.42
Apex Healthcare Bhd had a gross margin of 22.24% for the quarter that ended in Sep. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Apex Healthcare Bhd was 1.50% per year.
Apex Healthcare Bhd (XKLS:7090) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Apex Healthcare Bhd had a gross margin of 22.24% for the quarter that ended in Sep. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Apex Healthcare Bhd Gross Margin % Related Terms
Apex Healthcare Bhd Gross Margin % Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7090 vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Apex Healthcare Bhd (XKLS:7090) has a Gross Margin % of 22.24% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Apex Healthcare Bhd and its competitors. This is near median its historical median of 22.49. Over the past decade, Apex Healthcare Bhd's Gross Margin % has ranged from 20.88 to 23.77.
Is Apex Healthcare Bhd's Gross Margin % too high?
Apex Healthcare Bhd's current Gross Margin % of 22.24% is near median its 10-year median of 22.49. Over the past 10 years, this metric has ranged from a low of 20.88 to a high of 23.77. The Medical Distribution industry median Gross Margin % is 14.90. Apex Healthcare Bhd's value of 22.24% is 49.3% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Gross Margin % compare to MCK and COR?
Apex Healthcare Bhd's Gross Margin % of 22.24% can be compared against companies in the Medical Distribution industry. The industry median Gross Margin % is 14.90. Apex Healthcare Bhd's value of 22.24% is 49.3% above this benchmark. Historically, Apex Healthcare Bhd's own Gross Margin % has ranged from 20.88 to 23.77 over the past decade. While the company's 10-year median is 22.49 vs. the industry median of 14.90, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current Gross Margin % of 22.24% is 49.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current Gross Margin % is 22.24%, which is near median its own 10-year median of 22.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Gross Margin % of 22.24%. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Gross Margin % is 22.24%, which is near median its 10-year median of 22.49 and 49.3% above the Medical Distribution industry median of 14.90. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Gross Margin % is 22.24% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
Gross Margin %: 22.24% (near median its 10-year median of 22.49)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 49.3% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
